So, heres an area thats being damaged by free radicals, thats low in glutathione, and therefore is at more risk for free-radical damage, says Perlmutter
All reported observations remain confined to preclinical experimental systems and are presented solely for investigational and analytical purposes
There are no active IND applications or FDA-registered human clinical trials for BPC-157
Treatment plans are continuously adjusted based on patient progress and evolving health needs
293 Mirvetuximab soravtansine, the first FR-targeting antibodydrug conjugate (ADC), achieves OS benefits in platinum-resistant ovarian cancer
However, in preclinical studies, BPC-157 has been examined in animal models involving the gut, muscles, tendons, ligaments, and nervous system